GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Cyclically Adjusted Price-to-FCF

Beijing Tiantan Biological Products (SHSE:600161) Cyclically Adjusted Price-to-FCF : 194.94 (As of Jun. 09, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Cyclically Adjusted Price-to-FCF?

As of today (2024-06-09), Beijing Tiantan Biological Products's current share price is ¥31.19. Beijing Tiantan Biological Products's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.16. Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF for today is 194.94.

The historical rank and industry rank for Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:600161' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 168.75   Med: 529.03   Max: 2734.03
Current: 198.88

During the past years, Beijing Tiantan Biological Products's highest Cyclically Adjusted Price-to-FCF was 2734.03. The lowest was 168.75. And the median was 529.03.

SHSE:600161's Cyclically Adjusted Price-to-FCF is ranked worse than
83.81% of 105 companies
in the Biotechnology industry
Industry Median: 49.53 vs SHSE:600161: 198.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Beijing Tiantan Biological Products's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥0.114. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.16 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beijing Tiantan Biological Products Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Cyclically Adjusted Price-to-FCF Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,361.16 1,096.54 490.15 517.43 246.45

Beijing Tiantan Biological Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 293.79 246.75 162.77 246.45 172.35

Competitive Comparison of Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF falls into.



Beijing Tiantan Biological Products Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=31.19/0.16
=194.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tiantan Biological Products's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Beijing Tiantan Biological Products's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.114/115.2271*115.2271
=0.114

Current CPI (Mar. 2024) = 115.2271.

Beijing Tiantan Biological Products Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.132 98.200 0.155
201409 0.077 98.900 0.090
201412 -0.036 99.000 -0.042
201503 -0.064 99.900 -0.074
201506 0.060 99.500 0.069
201509 0.101 100.500 0.116
201512 0.051 100.600 0.058
201603 -0.033 102.200 -0.037
201606 0.001 101.400 0.001
201609 -0.002 102.400 -0.002
201612 0.182 102.600 0.204
201703 -0.125 103.200 -0.140
201706 -0.033 103.100 -0.037
201709 0.029 104.100 0.032
201712 0.080 104.500 0.088
201803 -0.073 105.300 -0.080
201806 0.221 104.900 0.243
201809 0.122 106.600 0.132
201812 -0.023 106.500 -0.025
201903 0.163 107.700 0.174
201906 -0.007 107.700 -0.007
201909 0.060 109.800 0.063
201912 -0.139 111.200 -0.144
202003 0.212 112.300 0.218
202006 0.110 110.400 0.115
202009 0.023 111.700 0.024
202012 -0.268 111.500 -0.277
202103 0.093 112.662 0.095
202106 0.055 111.769 0.057
202109 -0.078 112.215 -0.080
202112 -0.192 113.108 -0.196
202203 -0.038 114.335 -0.038
202206 0.158 114.558 0.159
202209 -0.057 115.339 -0.057
202212 -0.217 115.116 -0.217
202303 0.256 115.116 0.256
202306 0.219 114.558 0.220
202309 0.513 115.339 0.513
202312 -0.174 114.781 -0.175
202403 0.114 115.227 0.114

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beijing Tiantan Biological Products  (SHSE:600161) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Beijing Tiantan Biological Products Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tiantan Biological Products (SHSE:600161) Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.
Executives
Wang Jian Ming Supervisors
Liu Ya Na Directors, senior managers
Fu Dao Xing Directors, senior managers
He Yan Lin Directors, senior managers
Hu Li Gang Director
Ci Xiang senior management
Yang Hui Chuan Director
Zhang Yi senior management
Wu Zhen Shan senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines